The clinical relevance of OSM in inflammatory diseases: a comprehensive review.

Wolf, Cody L; Pruett, Clyde; Lighter, Darren; Jorcyk, Cheryl L

Wolf, Cody L; Pruett, Clyde; Lighter, Darren; Jorcyk, Cheryl L.

Affiliation

Wolf CL; Department of Biomolecular Sciences, Boise State University, Boise, ID, United States.
Pruett C; Department of Biological Sciences, Boise State University, Boise, ID, United States.
Lighter D; Department of Biological Sciences, Boise State University, Boise, ID, United States.
Jorcyk CL; Department of Biomolecular Sciences, Boise State University, Boise, ID, United States.

Front Immunol ; 14: 1239732, 2023.

Article in En | MEDLINE | ID: mdl-37841259

Subject(s)

COVID-19; Neoplasms; Humans; Oncostatin M/metabolism; Clinical Relevance; Phosphatidylinositol 3-Kinases

Key words

cancer; cytokine; drug development; inflammatory diseases; metastasis; oncostatin M (OSM); oncostatin M receptor beta (OSMRß); therapeutics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: United States Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google